The Future of Healthcare: Interoperability and the Patient Experience
World Pharma Today Magazine | For the C-level Pharma Executives
by content
13h ago
Fragmentation in healthcare data is a stark reality today. Many patients’ medical records lie dispersed among several filing cabinets, each originating from a separate physician’s office, hospital, or laboratory. Such fragmentation of medical records into discrete systems often breeds challenges for healthcare professionals to fully understand a patient’s condition. This leads to frustration for patients […] The post The Future of Healthcare: Interoperability and the Patient Experience first appeared on World Pharma Today ..read more
Visit website
ChargePoint to expand product range by investing in a dedicated multi-million-pound single-use manufacturing facility
World Pharma Today Magazine | For the C-level Pharma Executives
by content
13h ago
ChargePoint Technology, a specialist in powder and liquid transfer, has invested in a new manufacturing facility dedicated to its single-use products in Speke, Liverpool, to address an increased demand in the market for disposable technologies and equipment. The new site will boast a new high-tech cleanroom alongside a temperature and humidity-controlled storage facility for single-use […] The post ChargePoint to expand product range by investing in a dedicated multi-million-pound single-use manufacturing facility first appeared on World Pharma Today ..read more
Visit website
Bormioli Pharma launches the 3rd edition of its ESG Report, reaching the 45% of sustainable materials in sold products with its EcoPositive range
World Pharma Today Magazine | For the C-level Pharma Executives
by content
13h ago
Bormioli Pharma, an international leader in pharmaceutical packaging and medical devices, announced the third edition of its Sustainability Report. This edition outlines and consolidates the strong progress Bormioli Pharma has made in promoting sustainable growth in the communities where the Company live and work and highlights its strong commitment to supporting the pharmaceutical industry in […] The post Bormioli Pharma launches the 3rd edition of its ESG Report, reaching the 45% of sustainable materials in sold products with its EcoPositive range first appeared on World Pharma Today ..read more
Visit website
EMA Offers Plans To Enhance Availability of Vital Medicines
World Pharma Today Magazine | For the C-level Pharma Executives
by content
2d ago
As the EU health ministers go on to gather in Brussels on April 23–24 in order to discuss access when it comes to critical medicines and go on to formally launch the Critical Medicines Alliance, the European Medicines Agency- EMA has gone ahead and taken a step further as well as published its own recommendations […] The post EMA Offers Plans To Enhance Availability of Vital Medicines first appeared on World Pharma Today ..read more
Visit website
Schreiner MediPharm Introduces Late-Stage Customization Service for Its RFID-Labels
World Pharma Today Magazine | For the C-level Pharma Executives
by content
4d ago
Schreiner MediPharm, a Germany-based global provider of innovative functional label solutions for the healthcare industry, has introduced late-stage customization capabilities for its RFID-Labels series. The new service offering enables the company’s smart labels to be supplied on short notice with order-specific programming for their integrated RFID chips. The pharmaceutical industry is confronted with continually changing […] The post Schreiner MediPharm Introduces Late-Stage Customization Service for Its RFID-Labels first appeared on World Pharma Today ..read more
Visit website
Ardena’s Nanomedicines Facility Marks €20 Million Expansion with first GMP approval
World Pharma Today Magazine | For the C-level Pharma Executives
by content
4d ago
Ardena, a leading Contract Development and Manufacturing Organization (CDMO) specializing in bringing molecules to clinic, has received Good Manufacturing Practice (GMP) approval from the Dutch Healthcare Authority for its new analytical laboratories in its expanded nanomedicines facility. The facility includes state-of-the-art GMP-compliant cleanrooms to support Ardena’s growing nanomedicines business, as well as laboratories for process […] The post Ardena’s Nanomedicines Facility Marks €20 Million Expansion with first GMP approval first appeared on World Pharma Today ..read more
Visit website
Latest real-world evidence presented at WCO-IOF-ESCEO assesses how EVENITY can help to close the treatment gap in osteoporosis
World Pharma Today Magazine | For the C-level Pharma Executives
by content
4d ago
UCB, a global biopharmaceutical company announced key findings from the first retrospective patient cohort study in Denmark to observe the characteristics of patients selected for romosozumab treatment in routine clinical practice. The data were presented as a poster presentation at the World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO) 2024 in London. The observational, […] The post Latest real-world evidence presented at WCO-IOF-ESCEO assesses how EVENITY can help to close the treatment gap in osteoporosis first appeared on World Pharma Today ..read more
Visit website
Qinecsa Solutions announces acquisition of Insife to expand its end-to-end pharmacovigilance technology solutions
World Pharma Today Magazine | For the C-level Pharma Executives
by content
4d ago
Qinecsa Solutions (Qinecsa), specialists in technology-led end-to-end pharmacovigilance solutions, proudly announces its acquisition of Insife ApS (Insife), a well-established Danish-based software, technology, and consultancy firm specializing in developing revolutionary pharmacovigilance platforms. This acquisition is in alignment with Qinecsa’s vision, playing a crucial role in the company’s pursuit to become the leading provider of digital pharmacovigilance […] The post Qinecsa Solutions announces acquisition of Insife to expand its end-to-end pharmacovigilance technology solutions first a ..read more
Visit website
Cell & Gene Therapies: FDA Regulatory Considerations In 2024
World Pharma Today Magazine | For the C-level Pharma Executives
by content
1w ago
The fact is that most in the biotech industry know that cell and gene therapies- CGT are regulated across the U.S. as biological products by the FDA’s Center for Biologics Research and Evaluation- BER and need approval of a biologics license application- BLA under Section 351 of the Public Health Service Act before being marketed. […] The post Cell & Gene Therapies: FDA Regulatory Considerations In 2024 first appeared on World Pharma Today ..read more
Visit website
Can Clinical Research Spectrum Make The Most of Gene Therapy
World Pharma Today Magazine | For the C-level Pharma Executives
by content
1w ago
It is a well-established fact that gene therapy research happens to be booming. Since the U.S. Food and Drug Administration- FDA issued its first approval when it comes to gene therapy in 2017, oncology researchers have gone on to be breaking barriers as far as gene therapy trials are concerned, which was then followed by […] The post Can Clinical Research Spectrum Make The Most of Gene Therapy first appeared on World Pharma Today ..read more
Visit website

Follow World Pharma Today Magazine | For the C-level Pharma Executives on FeedSpot

Continue with Google
Continue with Apple
OR